Arachidonate Metabolites and Serotonin Contraction of Femoral Arteries from DOCA-salt Hypertensive Rats

References

• Rawadi C, Heimburger M, Dour M, Midol-Monnet M, Beslot F, Cohen Y. Uptake of 5- hydroxytryptamine in rat isolated atria. Gen Pharmacol 1992; 23: 613–7
   PubMedGoogle Scholar
• Szabo C, Hardebo JE, Owman C. An amplifying effect of exogenous and neurally stored 5-hydroxytryptamine on the neurogenic contraction in rat tail artery. Br J Pharmacol 1991; 102: 401–7
   PubMedGoogle Scholar
• Balasubramaniam G, Lee HS, Mah SC. Antihypertensive action of ketanserin in DOCA -salt hypertensive rats. Can J Pharmacol 1994; 72: 127, (Suppl 1)
   Google Scholar
• Mecca TE, Webb RC. Vascular responses to serotonin in steroid hypertensive rats. Hypertension 1985; 6: 887–92
   Google Scholar
• Storm DS, Webb RC. Alpha adrenergic receptors and 45Ca2+ efflux in arteries from deoxycorticosterone acetate hypertensive rats. Hypertension 1992; 19: 734–8
   PubMed Web of Science ®Google Scholar
• Chandra M, Chandra N. Serotonergic mechanisms in hypertension. Int J Cardiol 1993; 42: 189–96
   PubMed Web of Science ®Google Scholar
• Uehara Y, Numabe A, Hirawa N, Ishimitsu T, Takada S, Sugimoto T, Yagi S. Alterations to the vascular vasodepressor prostaglandin system in DOCA -salt hypertensive rats and their enzymatic analysis. J Hypertension 1988; S392–4, [Suppl 6]
   Google Scholar
• Perry PA, Webb RC. Agonist sensitive calcium stores in arteries from steroid hypertensive rats. Hypertension 1991; 17: 603–11
   PubMed Web of Science ®Google Scholar
• Houston DS, Vanhoutte PM. Serotonin and the vascular system. Role in health and disease, and implications for therapy. Drugs 1986; 31: 149–63
   PubMed Web of Science ®Google Scholar
• Auch-Schwelk S, Vanhoutte PM. Endothelium -derived contracting factor released by serotonin in the aorta of the spontaneously hypertensive rat. Am J Hypertens 1991; 4: 769–72
   PubMed Web of Science ®Google Scholar
• Tuncer M, Vanhoutte PM. Serotonin releases a vasoconstrictor prostanoid in the kidney of the aging spontaneously hypertensive rat. Blood Pressure 1993; 2: 142–5
   PubMedGoogle Scholar
• Stroebel M, Goppelt-Stuebe M. Signal transduction pathways responsible for serotonin-mediated prostaglandin G/H synthase expression in rat mensangial cells. J Biol Chem 1994; 269: 22592–7
   Google Scholar
• Miyake R, Gross RW. Multiple phospholipase A2 activities in canine vascular smooth muscle. Biochim Biophys Acta 1992; 1165: 167–76
   PubMed Web of Science ®Google Scholar
• Moncada S, Vane JR. Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2 and prostacyclin. Pharmacol Rev 1978; 30: 293–331
   PubMed Web of Science ®Google Scholar
• Needleman P, Isakson PC. Intrinsic prostaglandin biosynthesis in blood vessel. “Handbook of Physiology, Section 2, the Cardiovascular System”, DF Bohr, AP Somlyo, HV. Sparks, Jr. Am Physiological Society, Bethesda MD, 613–18
   Google Scholar
• Lockette WE, Webb RC. Vascular responses to sodium arachidonate in experimental hypertension. Proc Soc Exp Biol Med 1985; 178: 536–45
   PubMedGoogle Scholar
• Suba EA, Both BL. Prostaglandins activate phosphoi-nositide metabolism in rat aorta. Ear J Pharmacol 1987; 136: 325–32
   PubMedGoogle Scholar
• Heaslip RI, Sickels BD. Evidence that prostaglandins can contract the rat aorta via a novel protein kinase C -dependent mechanism. J Pharmacol Exp Ther 1989; 250: 44–51
   PubMedGoogle Scholar
• Junstad M, Wennmalm A. On the release of prostaglandin E2 from the rabbit heart following infusion of noradrenaline. Acta Physiol Scand 1973; 87: 573–4
   PubMedGoogle Scholar
• Grodzinska L, Gryglewski RJ. Angiotensin-induced release of prostacyclin from perfused organs. Pharmacol Res Commun 1980; 12: 339–47
   PubMedGoogle Scholar
• Sametz W, Juan H. Release of different prostaglandins from vascular tissue by different stimulators. Prost Leuk Med 1982; 9: 593–602
   PubMedGoogle Scholar
• lnoue Y, Fishman PH, Rebois RV. Differential activation of the stimulatory and inhibitory guanine nucleotide-binding proteins by fluoroaluminate in cells and in membranes. J Biol Chem 1990; 265: 1064–51
   Google Scholar
• Markov CM. The role of prostaglandins in the patho-genesis of hypertension. Clin Sci Mol Med 1978; 455: 207s–10
   Google Scholar
• Spokas EG, Quilley J, McGiff JC. Prostaglandins in hypertension. Hypertension, pathology and treatment, J. Genest, O Kuchel, P Homer, M. Cantin. McGraw-Hill, New York, NY 1983; 000, 373
   Google Scholar
• McGiff JC, Quilley J. Prostaglandins, kinins and the regulation of blood pressure. Clin Exp Hypertens 1980; 2: 729–40
   PubMed Web of Science ®Google Scholar
• Laborit H, Valette N. The effect of arachidonate on experimental arterial hypertension in the rat. Agressologie 1973; 14: 387–93
   PubMedGoogle Scholar
• Greenberg S. Properties of intestinal and cutaneous arteries and veins in two- kidney one-clip Goldblatt hypertension. Am J Physiol 1981; 241: H525–40
   Google Scholar
• Nasjletti A, Malik KU. Interrelations between prostaglandins and vasoconstrictor hormones: contribution to blood pressure regulation. Fed Proc 1982; 41: 2394–9
   PubMedGoogle Scholar
• Pace-Asciak CR, Carrara MC, Rangaraj G, Nicolav KC. Enhanced formation of PGI2 a potent hypotensive substance, by aortic rings and homogenates of the spontaneously hypertensiverat. Prostaglandins 1978; 15: 1005–12
   PubMedGoogle Scholar
• Limas C, Goldman P, Limas CJ, Iwai J. Effect of salt on prostaglandin metabolism in hypertension -prone and -resistant Dahl rats. Hypertension 1982; 3: 219–24
   Google Scholar
• Limas CJ, Limas C. Vascular prostaglandin synthesis in the spontaneously hypertensive rat. Am J Physiol 1977; 233: H493–9
   PubMed Web of Science ®Google Scholar
• Martin K, Zipser R, Horton R. Effect of prostaglandin inhibition on the hypertensive action of sodium -retaining steroids. Hypertension 1981; 3: 622–8
   PubMed Web of Science ®Google Scholar
• Bayorh MA, Zukowskai- Grojec Z, Ezra D, Feuverstein GZ, Kopkin IJ. Cardiovascular and sympathetic responses to chronic arachidonate in SHR and WKY rats. Hypertension 1983; 5: 172–9
   PubMed Web of Science ®Google Scholar
• Pugsley DJ, Bellin LJ, Petro RP. Renal prostaglandin synthesis in hypertension induced by deoxycorticosterone and sodium chloride in the rat. Clin Sci Med 1975; 253s, [Suppl 51]
   Google Scholar
• Yon J, Kelly G, Bartter FC. Effect of indomethacin on renal function and plasma renin activity in dogs with chronic neurovascular hypertension. Nephron 1979; 24: 278–82
   PubMedGoogle Scholar
• Imanishi M, Kawamura M, Akabane S, Matsushima Y, Kuramochi M, Ito K. Aspirin lowers blood pressure in patients with renovascular hypertension. Hypertension 1989; 14: 461–8
   PubMedGoogle Scholar
• Wallenburg HC, Dekker GA, Makovitz JW, Tormans P. Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae. Lancet 1986; i: 1–3
   Google Scholar
• Taube C, Martin S, Kohler AH, Kohler AR, Mest HJ. Influence of acetylsalicylic acid and BM 13177 on blood pressure and efficacy of antihypertensive drugs in spontaneously hypertensive rats. Biomed Biochim Acta 1988; 47: s94–9
   Google Scholar
• Quilley CP, Chiba S, Quilley J, McGiff JC. Aspirin enhances the antihypertensive effect of captopril in spontaneously hypertensive rats. Hypertension 1987; 10: 294–302
   PubMedGoogle Scholar
• Rahmani MA, Mangroo T, Bienaime M, Wiggins S, Williams J. Effect of aspirin on the contractility of aortic smooth muscle in female spontaneously hypertensive rats. Artery 1992; 19: 271–83
   PubMedGoogle Scholar
• Richard M, Vignon E, Peschard MJ, Broquet P, Carrel JP, Louisot P. Serotonin-stimulated phospholipase A2 and collagenase activation in chondrocytes from human osteoarthritic articularcartilage. FEBS Lett 1991; 278: 38–40
   PubMedGoogle Scholar
• Nadasy GL, Szekacs B, Juhasz I, Feher J, Kavach AG, Monos E. Role of endothelium, oxygen and ionic milieu in the prostacyclin and thromboxane production of rat aortic tissue slices. Acta Physiol Hung 1991; 78: 77–87
   PubMed Web of Science ®Google Scholar